Which test is used for syphilis screening in prenatal labs?

Study for the Step 3 UWSA Exam with our challenging quiz. Prepare with detailed explanations for each question, ensuring you're well-equipped for success. Enhance your understanding and boost your exam confidence!

Multiple Choice

Which test is used for syphilis screening in prenatal labs?

Explanation:
Screening for syphilis in prenatal care uses a non-treponemal serologic test, chosen for rapid, inexpensive, broad screening. The Rapid Plasma Reagin (RPR) test detects antibodies to a cardiolipin-containing complex and is used to screen pregnant patients. If the result is positive, a treponemal-specific test (such as FTA-ABS or TPPA) confirms infection, since non-treponemal tests can be falsely positive in pregnancy or other conditions. In prenatal labs, all pregnant women are screened early to prevent congenital syphilis, and RPR’s speed and cost-effectiveness make it the standard initial screen. The other options measure pregnancy status (HCG), hepatitis B status (HepB surface antigen), or rubella immunity (Rubella IgG), not syphilis.

Screening for syphilis in prenatal care uses a non-treponemal serologic test, chosen for rapid, inexpensive, broad screening. The Rapid Plasma Reagin (RPR) test detects antibodies to a cardiolipin-containing complex and is used to screen pregnant patients. If the result is positive, a treponemal-specific test (such as FTA-ABS or TPPA) confirms infection, since non-treponemal tests can be falsely positive in pregnancy or other conditions. In prenatal labs, all pregnant women are screened early to prevent congenital syphilis, and RPR’s speed and cost-effectiveness make it the standard initial screen. The other options measure pregnancy status (HCG), hepatitis B status (HepB surface antigen), or rubella immunity (Rubella IgG), not syphilis.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy